Cancer Risk Reduction
& Surveillance (CTC Testing)
Proactive cancer risk assessment and monitoring using Circulating
Tumour Cell (CTC) testing, alongside integrative strategies to reduce
recurrence risk and support immune surveillance. For those with a
personal or family history of cancer seeking evidence-based prevention.
What You Can Expect
Circulating Tumour Cell (CTC) testing for proactive monitoring
Comprehensive cancer risk assessment including relevant biomarkers
Personalised nutrition and integrative strategies to support immune resilience
Collaboration with oncology and specialist care as required
Ongoing monitoring and review
Programme Outcomes?
- Detect cancer risk early
- Implement strategies to reduce recurrence
- Gain clarity and peace of mind
Investment
CTC testing and laboratory costs additional to consultation fees.
Customised plan quoted on assessment.